These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 20582415

  • 1. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major.
    Baldini M, Forti S, Marcon A, Ulivieri FM, Orsatti A, Tampieri B, Airaghi L, Zanaboni L, Cappellini MD.
    Ann Hematol; 2010 Dec; 89(12):1207-13. PubMed ID: 20582415
    [Abstract] [Full Text] [Related]

  • 2. Low bone mineral density in adolescents with beta-thalassemia.
    Vogiatzi MG, Autio KA, Mait JE, Schneider R, Lesser M, Giardina PJ.
    Ann N Y Acad Sci; 2005 Dec; 1054():462-6. PubMed ID: 16339698
    [Abstract] [Full Text] [Related]

  • 3. Gender differences in the prevalence and severity of bone disease in thalassaemia.
    Kyriakou A, Savva SC, Savvides I, Pangalou E, Ioannou YS, Christou S, Skordis N.
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
    [Abstract] [Full Text] [Related]

  • 4. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR, De Sanctis V, Gilli G.
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
    Hamilton EJ, Rakic V, Davis WA, Chubb SA, Kamber N, Prince RL, Davis TM.
    Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density and vitamin D receptor polymorphism in beta-thalassemia major.
    El-Edel RH, Ghonaim MM, Abo-Salem OM, El-Nemr FM.
    Pak J Pharm Sci; 2010 Jan; 23(1):89-96. PubMed ID: 20067873
    [Abstract] [Full Text] [Related]

  • 7. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566
    [Abstract] [Full Text] [Related]

  • 8. Survival and complications in thalassemia.
    Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Origa R, Piga A, Romeo MA, Zhao H, Cnaan A.
    Ann N Y Acad Sci; 2005 Jan 30; 1054():40-7. PubMed ID: 16339650
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral density in Iranian adolescents and young adults with beta-thalassemia major.
    Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pakbaz Z, Tabatabaie SM, Bouzari N, Pourzahedgilani N, Azarkeivan A, Hashemi SR, Moosavi F, Alebouyeh M, Vosough P, Kimiagar M, Shamshirsaz AA, Moradi M, Habibzadeh MR, Nobakhthaghighi N, Larijani B.
    Pediatr Hematol Oncol; 2007 Jan 30; 24(7):469-79. PubMed ID: 17786783
    [Abstract] [Full Text] [Related]

  • 10. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA, Sarna L, Oka RK, Vredevoe DL, Rettig MB, Aronson WJ.
    Urology; 2004 Aug 30; 64(2):335-40. PubMed ID: 15302490
    [Abstract] [Full Text] [Related]

  • 11. Relation between BMD and biochemical, transfusion and endocrinological parameters in pediatric thalassemic patients.
    Mohseni F, Mohajeri-Tehrani MR, Larijani B, Hamidi Z.
    Arch Osteoporos; 2014 Aug 30; 9():174. PubMed ID: 24652076
    [Abstract] [Full Text] [Related]

  • 12. Osteopenia in Puerto Ricans with Crohn's disease.
    Chinea B, Rosa A, Oharriz JJ, Ramírez M, Haddock L, Pérez C, Torres EA.
    P R Health Sci J; 2000 Dec 30; 19(4):329-33. PubMed ID: 11293884
    [Abstract] [Full Text] [Related]

  • 13. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
    Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O, Frediani B, Cantatore F, Pellerito R, Bartolone S, La Montagna G, Adami S.
    J Rheumatol; 2000 Nov 30; 27(11):2582-9. PubMed ID: 11093437
    [Abstract] [Full Text] [Related]

  • 14. The impact of genotype on endocrine complications in thalassaemia major.
    Skordis N, Michaelidou M, Savva SC, Ioannou Y, Rousounides A, Kleanthous M, Skordos G, Christou S.
    Eur J Haematol; 2006 Aug 30; 77(2):150-6. PubMed ID: 16800840
    [Abstract] [Full Text] [Related]

  • 15. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D.
    Am J Gastroenterol; 1998 Sep 30; 93(9):1483-90. PubMed ID: 9732930
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy x-ray absorptiometry and quantitative computed tomography: a comparison study.
    Angelopoulos NG, Katounda E, Rombopoulos G, Goula A, Kaltzidou V, Kaltsas D, Ioannis P, Tolis G.
    J Pediatr Hematol Oncol; 2006 Feb 30; 28(2):73-8. PubMed ID: 16462577
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D receptor gene, biochemical bone markers and bone mineral density in Mexican women on dialysis.
    Avila M, Prado C, Ventura MD, Mora C, Briones D, Valdez H, Hurtado ME, Lindholm B, Qureshi A, Castillo-Henkel C, Paniagua R.
    Nephrol Dial Transplant; 2010 Jul 30; 25(7):2259-65. PubMed ID: 20124547
    [Abstract] [Full Text] [Related]

  • 18. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
    Brzóska MM, Moniuszko-Jakoniuk J.
    Bone; 2004 Nov 30; 35(5):1180-91. PubMed ID: 15542044
    [Abstract] [Full Text] [Related]

  • 19. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C, Pischulti G, Klaus J, Rieber A, Brückel J, Böhm BO, Adler G, Reinshagen M.
    Z Gastroenterol; 1999 Jan 30; 37(1):5-12. PubMed ID: 10091278
    [Abstract] [Full Text] [Related]

  • 20. Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.
    Pietrapertosa AC, Minenna G, Colella SM, Santeramo TM, Renni R, D'Amore M.
    Panminerva Med; 2009 Mar 30; 51(1):17-23. PubMed ID: 19352306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.